Ovarian Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Ovarian Cancer, including details on symptoms, causes, treatment, information.

Volume 5 (2008), Issue 5 (May)

1. Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome.
   BMC Cancer, 8: 101. [Abstract] [Full-text]
2. Ovarian cancer risk in Polish BRCA1 mutation carriers is not associated with the prohibitin 3' untranslated region polymorphism.
   BMC Cancer, 8: 90. [Abstract] [Full-text]
3. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer.
   Proc Natl Acad Sci U S A, 105(19): 7004-9. [Abstract] [Full-text]
4. Valproic acid resensitizes cisplatin-resistant ovarian cancer cells.
   Cancer Sci, 99(6): 1218-26. [Abstract] [Full-text]
5. Midkine and its clinical significance in endometrial carcinoma.
   Cancer Sci, 99(6): 1125-30. [Abstract] [Full-text]
6. Tissue AP-2gamma and Oct-3/4, and serum CA 125 as diagnostic and prognostic markers of malignant ovarian germ cell tumors.
   Tumour Biol, 29(1): 50-6. [Abstract] [Full-text]
7. Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma.
   Lab Invest, 88(6): 602-14. [Abstract] [Full-text]
8. Bilateral phlegmasia dolens associated with Trousseau's syndrome: a case report.
   Arch Phys Med Rehabil, 89(6): 1187-90. [Abstract] [Full-text]
9. Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: involvement in p53 regulation and cisplatin resistance.
   Br J Cancer, 98(11): 1803-9. [Abstract] [Full-text]
10. Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity.
    Br J Cancer, 98(11): 1781-3. [Abstract] [Full-text]
11. A phase Ib trial of docetaxel, carboplatin and erlotinib in ovarian, fallopian tube and primary peritoneal cancers.
    Br J Cancer, 98(11): 1774-80. [Abstract] [Full-text]
12. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
    J Clin Oncol, 26(16): 2683-9. [Abstract] [Full-text]
13. Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancer.
    J Clin Oncol, 26(16): 2674-82. [Abstract] [Full-text]

© 2004-2008 Ovarian Cancer Research Today. All Rights Reserved.